• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
WANG Hua, XU Yuansheng, SONG Yan. Therapeutic effect of anti-inflammatory tripeptide KdPT on ophthalmoxerosis in mice[J]. Journal of China Pharmaceutical University, 2021, 52(1): 100-103. DOI: 10.11665/j.issn.1000-5048.20210114
Citation: WANG Hua, XU Yuansheng, SONG Yan. Therapeutic effect of anti-inflammatory tripeptide KdPT on ophthalmoxerosis in mice[J]. Journal of China Pharmaceutical University, 2021, 52(1): 100-103. DOI: 10.11665/j.issn.1000-5048.20210114

Therapeutic effect of anti-inflammatory tripeptide KdPT on ophthalmoxerosis in mice

More Information
  • Received Date: October 21, 2020
  • Revised Date: December 16, 2020
  • This study was designed to investigate the therapeutic effect of anti-inflammatory tripeptide KdPT on ophthalmoxerosis. Male BALB/c mice, 8-week old, were treated with 0.2% benzalkonium chloride solution to establish the ophthalmoxerosis model. Four weeks after modeling, the mice were randomly divided into control group, positive group and the low, medium, high dose groups of KdPT. Each group was given normal saline, artificial tears and 1, 10, 100 μg/mL KdPT, respectively. After 3, 5, 7, 10 and 14 days of treatment, the morphology of the eye surface was observed, and the fluorescein sodium staining score was performed. The amount of tear secretion was measured by phenol red cotton thread and the right corneas were taken out for histopathological analysis after 14 days of treatment. Data showed that there was no significant abnormality in general state and the weight of mice in each group at each time point of treatment. After 14 days of treatment, KdPT can promote the secretion of tear, repair the damaged corneal epithelium, and showed a significant therapeutic effect on ophthalmoxerosis in mice. Based on the data, it is possible for KdPT to be developed as a novel drug for ophthalmoxerosis.
  • [1]
    .Chin J Ophthalmol, 2013,49(1): 73-75.
    [2]
    Liu ZG, Yang WZ. Dry eye and its pathogenesis[J]. Ophthalmol CHN. 2005,14(5): 343-345.
    [3]
    Wei Y, Asbell PA. The core mechanism of dry eye disease is inflammation[J]. Eye Contact Lens, 2014, 40(4): 248-256.
    [4]
    Yamaguchi T. Inflammatory response in dry eye[J]. Invest Ophthalmol Vis Sci, 2018, 59(14): DES192-DES199.
    [5]
    Jung HH, Ji YS, Sung MS, et al. Long-term outcome of treatment with topical corticosteroids for severe dry eye associated with Sj?gren's syndrome[J]. Chonnam Med J, 2015, 51(1): 26-32.
    [6]
    de Paiva CS, Pflugfelder SC, Ng SM, et al. Topical cyclosporine A therapy for dry eye syndrome[J]. Cochrane Database Syst Rev, 2019, 9: CD010051.
    [7]
    Pavan J, Lukenda A, Stambuk N, et al. Effects of alpha-MSH on corneal epithelial lesions in rats[J]. Coll Antropol, 2012, 36(4): 1407-1411.
    [8]
    Ru YS, Huang Y, Liu HJ, et al. Α-Melanocyte-stimulating hormone ameliorates ocular surface dysfunctions and lesions in a scopolamine-induced dry eye model via PKA-CREB and MEK-Erk pathways[J]. Sci Rep, 2015, 5: 18619.
    [9]
    Dou ZX, Ru YS, Liu HJ. Combinatorial protective effects of α-melanocyte-stimulating hormone and carboxymethylcellulose on ocular surface in dry eye rat model[J]. Chin J Exp Ophthalmol(中华实验眼科杂志),2017,35(6): 498-505.
    [10]
    Bettenworth D, Buyse M, B?hm M, et al. The tripeptide KdPT protects from intestinal inflammation and maintains intestinal barrier function[J]. Am J Pathol, 2011, 179(3): 1230-1242.
    [11]
    Kucharzik T, Lemmnitz G, Abels C, et al. Mo1216 tripeptide KdPT accelerates disease remission in patients with mild to moderate active ulcerative colitis[J]. Gastroenterology, 2014, 146(5): S-588.
    [12]
    Li CJ, Ge H, Cui LJ, et al. Molecular mechanism of action of K(D)PT as an IL-1RI antagonist for the treatment of rhinitis[J]. RSC Adv, 2014,4(89): 48741-48749.
    [13]
    Mykicki N, Klenner L, Baumann C, et al. The tripeptide KdPT ameliorates ongoing psoriasis-like skin inflammation in murine and human skin[J]. Exp Dermatol, 2017, 26(4): 328-334.
    [14]
    Narayanan S, Corrales RM, Farley W, et al. Interleukin-1 receptor-1-deficient mice show attenuated production of ocular surface inflammatory cytokines in experimental dry eye[J]. Cornea, 2008, 27(7): 811-817.
    [15]
    Yamada A, Arakaki R, Kudo Y, et al. Targeting IL-1 in Sj?gren's syndrome[J]. Expert Opin Ther Targets, 2013, 17(4): 393-401.
    [16]
    Vijmasi T, Chen FY, Chen YT, et al. Topical administration of interleukin-1 receptor antagonist as a therapy for aqueous-deficient dry eye in autoimmune disease[J]. Mol Vis, 2013, 19: 1957-1965.
  • Related Articles

    [1]LIN Lin, QI Xiaodong, LI Yongsu, YANG Yubo, YANG Minghua, CHEN Yi, KONG Lingyi, WANG Li. Identification of involatile chemical components from Moutai-flavored distiller’s grains[J]. Journal of China Pharmaceutical University, 2023, 54(4): 461-467. DOI: 10.11665/j.issn.1000-5048.2023040402
    [2]ZHANG Jing, LI Lun, ZHANG Mei, HU Xiaolong, WANG Hao. Research progress in chemical constituent and pharmacological activity of Punica granatum L.[J]. Journal of China Pharmaceutical University, 2023, 54(4): 421-430. DOI: 10.11665/j.issn.1000-5048.2023032101
    [3]SUN Biao, AO Yunlin, WANG Dezhi, WANG Junya, YE Wencai, ZHANG Xiaoqi. Chemical constituents of petroleum ether extract from the stems and leaves of Humulus scandens[J]. Journal of China Pharmaceutical University, 2022, 53(2): 178-184. DOI: 10.11665/j.issn.1000-5048.20220207
    [4]YANG Xiaojun, AI Fengfeng, LIN Junbing, TANG Jiangjiang. Chemical constituents extracted from Dictamnus dasycarpus and their α-glucosidase inhibitory activity[J]. Journal of China Pharmaceutical University, 2019, 50(1): 41-45. DOI: 10.11665/j.issn.1000-5048.20190105
    [5]Pham Thi Anh, LI Junyan, ZHANG Baobao, WANG Hao. Chemical constituents from the n-butanol portions of the fruits of Eucalyptus globulus[J]. Journal of China Pharmaceutical University, 2018, 49(4): 422-426. DOI: 10.11665/j.issn.1000-5048.20180406
    [6]MA Lin, ZHANG Yaozhou, DANG Jun. Chemical constituents from water extract of Armillaria luteo-virens[J]. Journal of China Pharmaceutical University, 2016, 47(3): 291-293. DOI: 10.11665/j.issn.1000-5048.20160307
    [7]YIN Minmin, YIN Zhiqi, ZHANG Jian, WANG Lei, YE Wencai. Chemical constituents from ethyl acetate extract of Cynanchum otophyllum Schneid.[J]. Journal of China Pharmaceutical University, 2013, 44(3): 213-218. DOI: 10.11665/j.issn.1000-5048.20130305
    [8]SUN Jing, YIN Zhi-qi, ZHANG Qing-wen, YE Wen-cai, WANG Yi-ta, ZHAO Shou-xun. Chemical constituents from ethyl acetate extract of Ganoderma lucidum[J]. Journal of China Pharmaceutical University, 2011, 42(3): 220-222.
    [9]Chemical constituents from n-butanol extract of the stems of Lonicera japonica[J]. Journal of China Pharmaceutical University, 2010, 41(4): 333-336.
    [10]Hypoglycemic Effects of Extracts and Constituents from Euonymus alatus[J]. Journal of China Pharmaceutical University, 2003, (2): 32-35.
  • Cited by

    Periodical cited type(3)

    1. 胡彤,李爽,钟卫鸿. 基于酸信号转导系统的细菌耐酸机制及其应用. 生物工程学报. 2024(03): 644-664 .
    2. 吴晓妍,吴剑梅,傅丹丹,涂健,宋祥军,邵颖,祁克宗. hipA对禽致病性大肠杆菌生物学特性和致病性的影响. 西北农林科技大学学报(自然科学版). 2023(08): 11-18+28 .
    3. 郝雪雁,刘梦晓,韩紫依,房立霞,曹英秀. 大肠杆菌的耐酸机制及其改造研究进展. 微生物学通报. 2023(10): 4667-4680 .

    Other cited types(1)

Catalog

    Article views (142) PDF downloads (809) Cited by(4)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return